| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/02/2008 | CN100358888C Novel guanidine mimics as factor Xa inhibitors |
| 01/02/2008 | CN100358581C Drug- or gene-carrier composition having lowered hemagglutinin activity |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/02/2008 | CN100358558C Formulation for treating cardiovascular and cerebrovascular disease and its preparation process and quality control method |
| 01/02/2008 | CN100358555C Chinese medicine for treating internal hemorrhage and its prepn process |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314940 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314874 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo |
| 01/01/2008 | US7314860 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 01/01/2008 | US7314728 Methods of treating peripheral arterial occlusions |
| 12/27/2007 | WO2007148752A1 Infusion preparation for dialysis patient |
| 12/27/2007 | WO2007148609A1 Ex vivo/in vivo proliferation of hematopoietic stem cell or hematopoietic progenitor cell by timp-3 |
| 12/27/2007 | WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299126 Substituted pyrrole-indoles |
| 12/27/2007 | US20070299076 Substituted 3-Amino-Pyrrolidino-4-Lactams |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299013 Exosite-Directed Thrombin Inhibitors |
| 12/27/2007 | US20070298125 Medical Solution, A Method For Producing Said Medical Solution And Use Thereof |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | DE102006020327A1 Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung Heterocyclic-substituted, fused pyrazole derivatives and their use |
| 12/27/2007 | CA2655728A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870100A1 Pharmaceutical composition for oral application comprising ethyl 3-(2-(4-(hexyloxycarbonylamidino)phenylaminomethyl)-1-methyl-1H-benzimidazole-5-carbonyl)-2-pyridylamino)propionate mesylate |
| 12/26/2007 | EP1869051A1 4-piperazinylthieno ý2,3-d¨pyrimidine compounds as platelet aggregation inhibitors |
| 12/26/2007 | EP1869010A1 3-sulfonylamino-pyrrolidine-2-one derivatives as factor xa inhibitors |
| 12/26/2007 | EP1525193B1 Acylaminothiazole derivatives, preparation and therapeutic use thereof |
| 12/26/2007 | EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 12/26/2007 | CN101094835A Novel dicarboxamide derivatives |
| 12/26/2007 | CN101094683A Anti-diabetic extract isolated from rauvolfia vomitoria and citrus aurantium, and methods of using same |
| 12/26/2007 | CN101094678A Blood cholesterol reducing oral composition |
| 12/26/2007 | CN101094671A Combination therapy comprising an adenosine a1 receptor antagonist and an aldosterone inhibitor |
| 12/26/2007 | CN101092612A New thrombin with hemostaitic activityin in category of snake poison of hundred-paced pit |
| 12/26/2007 | CN101091792A Multi-dose erythropoietin formulations |
| 12/26/2007 | CN101091738A Composition of medicine in use for treating cardiovascular disease and cerebrovascular disease, and preparation method |
| 12/26/2007 | CN101091721A Method for preparing new type asshide |
| 12/26/2007 | CN101091707A Medicinal usage of kuhseng extractive |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN100357430C 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity |
| 12/26/2007 | CN100357322C Disintegrating element for poisonous snake and its coding gene and use |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100356987C Thrombin-carrying bioabsorbable synthetic nonwoven fabric |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312321 Antibody to human enzymes of the metalloprotease family |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312078 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 12/25/2007 | US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders |
| 12/25/2007 | US7311908 Pharmaceutical compositions of fibrinolytic agent |
| 12/25/2007 | US7311849 Control device for the separate collection of blood components in output from a blood centrifugation cell |
| 12/21/2007 | WO2007146900A2 Antihypertensive therapy method |
| 12/21/2007 | WO2007146553A2 N-[2-[[(diaminomethylene)amino]oxy]ethyl]-3-[(2,2-difluoro-2-phenylethyl)amino]-6-methyl-2-oxo-1(2h)-pyrazineacetamide |
| 12/21/2007 | WO2007146438A1 Hif hydroxylase inhibitors for treatment of anemia of cancer |
| 12/21/2007 | WO2007146104A2 Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use |
| 12/21/2007 | WO2007145227A1 Hematopoietic stem cell proliferation promoter |
| 12/21/2007 | WO2007144379A1 Bicyclic compounds useful as cathepsin s inbhibitors |
| 12/21/2007 | CA2657951A1 Agents for promoting the growth of hematopoietic stem cells |
| 12/21/2007 | CA2655144A1 Antihypertensive therapy method |
| 12/20/2007 | US20070293572 Anti-Fatigue Composition |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293513 Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compound |
| 12/20/2007 | US20070293512 2-[4-(4-Chlorophenylthio)-3-nitrophenyl]-4-mercaptothiazolo[5,4-d]pyrimidine; hyperuricemia; gout |
| 12/20/2007 | US20070293499 Intracellular Kinase Inhibitors |
| 12/20/2007 | US20070293474 Combination of a DPP IV inhibitor and a cardiovascular compound |
| 12/20/2007 | US20070293422 Beta-Amyloid Inhibitors and Use Thereof |
| 12/20/2007 | US20070292543 Extracts From Roots And/Or Shoots Of Asparagus Officinalis L., Their Preparation And Their Use |
| 12/20/2007 | US20070292490 Production of tissue factor in plants |
| 12/20/2007 | US20070292388 In vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in medium comprising ligands of EGF receptor and GP130 receptor, such as EGF and LIF; insulin secreting cells obtainable by this method provide means for treatment of diabetes |
| 12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
| 12/19/2007 | EP1867639A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 12/19/2007 | EP1867331A1 Triazole derivative and the use thereof |
| 12/19/2007 | EP1866318A2 Thienopyridine compounds, and methods of use thereof |
| 12/19/2007 | EP1866317A1 4-piperazinothieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 12/19/2007 | EP1740538A4 Bicyclic heterocycles useful as serine protease inhibitors |
| 12/19/2007 | EP1470122B1 Rho-kinase inhibitors |
| 12/19/2007 | EP1230369B1 Polypeptide hormone phosphatonin |
| 12/19/2007 | EP1005341B1 Il-8 receptor antagonists |
| 12/19/2007 | EP0804440B1 Tricyclic benzazepine vasopressin antagonists |
| 12/19/2007 | CN101090731A Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 12/19/2007 | CN101089019A Polypeptides with antithrombotic activity and their prepn process and application |
| 12/19/2007 | CN101088531A Hematopoietic capsule for treating anemia |
| 12/19/2007 | CN101088516A Chinese medicine prepn for treating leukemia |
| 12/19/2007 | CN101088512A Prepn of Chinese medicine for treating aplastic anemia |
| 12/19/2007 | CN101088505A Nanometer breviscapine polymer particle prepn and its prepn process |
| 12/19/2007 | CN100355884C Novel earthworm fibrinolytic enzyme, its encoding sequence and uses |
| 12/19/2007 | CN100355783C Anti-coagulate protein and its coding gene and high effective expression method |
| 12/19/2007 | CN100355452C Carbonyl stress-ameliorating agents |